William John Jenkins
Director/Board Member at Apitope Technology (Bristol) Ltd.
Network origin in William John Jenkins first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA.
16
| Holding Company | Miscellaneous Commercial Services | 16 |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
BioVersys AG
 BioVersys AG Miscellaneous Commercial ServicesCommercial Services BioVersys AG operates as a holding company, which specializes in the research and development of small molecules acting on novel bacterial targets. Its research focuses on nosocomial infection and tuberculosis. The company was founded by Marc Gitzinger and Marcel Tigges on September 24, 2008 and is headquartered in Basel, Switzerland.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Glaxo Group Research Ltd.
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to William John Jenkins via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
English China Clays Plc
 English China Clays Plc Financial ConglomeratesFinance Part of Groupe Bruxelles Lambert SA, English China Clays Plc is an investment holding British company. The company is based in Reading, UK. English China Clays was acquired by Imetal Uk on May 04, 1999 for $1,247.67 million. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| CEPHEID | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | President Director/Board Member Corporate Officer/Principal | |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| TIGENIX NV | Medical Specialties | Director/Board Member Director/Board Member Public Communications Contact Corporate Officer/Principal | |
| COBHAM | Information Technology Services | Director/Board Member Corporate Officer/Principal | |
| HALMA PLC | Electronic Equipment/Instruments | Director/Board Member Chairman | |
| SENIOR PLC | Aerospace & Defense | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Director of Finance/CFO Undergraduate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Baxter Healthcare SA
 Baxter Healthcare SA Pharmaceuticals: MajorHealth Technology Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| University of Cambridge | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The University of Edinburgh | College/University | Director/Board Member Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman Chairman | |
| ELECTRICAL GEODESICS INC | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Hasselt University | College/University | Graduate Degree Doctorate Degree | |
Provensis Ltd.
 Provensis Ltd. Medical/Nursing ServicesHealth Services Part of Boston Scientific Corp., Provensis Ltd. is a British company that provides health care services. The company is based in Camberley, UK. The company was founded in 1999 by Paul Bernard Harper. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director/Board Member | |
Biotechnological Enzymatic Catalyse NV
 Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium. | Food: Major Diversified | Director/Board Member Director/Board Member | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg. | Investment Managers | Founder Private Equity Investor | |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | Biotechnology | Chairman Founder Chairman Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Life Sciences Development Campus NV
 Life Sciences Development Campus NV Miscellaneous Commercial ServicesCommercial Services Life Sciences Development Campus NV provides research and development services in the field of biomedical life sciences. The company is headquartered in Abis, BelGium. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Protherics Medicines Development Ltd.
 Protherics Medicines Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Protherics Medicines Development Ltd. develops, manufactures and commercializes pharmaceutical products. The company is based in London, UK. Founded in 1985. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Protherics UK Ltd.
 Protherics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., Protherics UK Ltd. is a pharmaceutical company founded in 1997. The company is based in Ceredigion, UK and manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Vesalius Biocapital II Partners SARL | Corporate Officer/Principal Founder | ||
Fast Forward Pharmaceuticals BV
 Fast Forward Pharmaceuticals BV Medical SpecialtiesHealth Technology Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
Biocompatibles UK Ltd.
 Biocompatibles UK Ltd. BiotechnologyHealth Technology Biocompatibles UK Ltd. manufactures and markets implantable products for patients. Biocompatibles UK Ltd. is based in Farnham, UK and has subsidiaries in the UK. It was founded in 2001. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director of Finance/CFO Director/Board Member |
Statistics
International
| United Kingdom | 29 |
| United States | 10 |
| Belgium | 8 |
| Netherlands | 3 |
| Luxembourg | 3 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 5 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 356 |
| Corporate Officer/Principal | 115 |
| Independent Dir/Board Member | 81 |
| Chairman | 74 |
| Chief Executive Officer | 56 |
Most connected contacts
| Insiders | |
|---|---|
| Tom Baruch | 55 |
| Frank Armstrong | 41 |
| John Brown | 36 |
| Pamela Louise Makin | 35 |
| Stéphane Verdood | 32 |
| Karen Wilson | 31 |
| Alain Parthoens | 29 |
| John Mendlein | 27 |
| Peter Chambré | 23 |
| Melanie Lee | 19 |
| Timothy Harris | 19 |
| Christine Soden | 18 |
| Nico Vandervelpen | 17 |
| Alison Wood | 17 |
| Malcolm Coster | 16 |
- Stock Market
- Insiders
- William John Jenkins
- Company connections
